The HIV/AIDS epidemic has heightened the globalization of disease. As a result, there is an increased need for globalized access to pharmaceuticals and development of public-private partnerships to collaborate efforts in the prevention, control, and treatment of HIV/AIDS.
The global dimension of HIV/AIDS prevention and control requires the convergence of multidisciplinary approaches from multilateral, bilateral and international health organizations, governments, and private industries. Governments are unable to sustain adequate service delivery and costs needed for disease prevention and treatment due to limited resources. This project aims to address issues related to HIV/AIDS prevention and treatment by exploring public-private partnerships through rational pharmaceutical management as a means to expand globalized access to pharmaceuticals.
The project research will consist of a desk review, stakeholder analysis, and roundtable discussion. Two reports will be created as a result of the investigation. The findings from the desk review and stakeholder analysis will be mapped in a report outlining the critical issues. A strategy report, based on the roundtable discussion, will be created and disseminated to stakeholders to facilitate collaborative efforts in public-private partnerships and rational pharmaceutical management.
Muhiuddin Haider (PI), Senior Associate, Center for International Health
More Private than Public?
Globalization Brown Bag, January 2002
Analysis of Experience: The Role of Public Private Partnerships in HIV/AIDS Prevention, Control, and Treatment Programming, Part 1: Conceptual Framework
Occasional Paper, CSGOP-03-17
Analysis of Experience: The Role of Public Private Partnerships in HIV/AIDS Prevention, Control, and Treatment Programming, Part 2: Case Studies
Occasional Paper, CSGOP-03-18
Analysis of Experience: The Role of Public Private Partnerships in HIV/AIDS Prevention, Control, and Treatment Programming, Part 3: Lessons Learned
Occasional Paper, CSGOP-03-19